Publications in collaboration with researchers from University of Oxford (14)

2022

  1. IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)

    Trials, Vol. 23, Núm. 1

  2. IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity

    Trials, Vol. 23, Núm. 1

  3. Pharmacological Probes to Validate Biomarkers for Analgesic Drug Development

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

2021

  1. IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)

    Trials, Vol. 22, Núm. 1

2019

  1. Cerebral oxidative metabolism mapping in four genetic mouse models of anxiety and mood disorders

    Behavioural Brain Research, Vol. 356, pp. 435-443

2011

  1. Shared changes in gene expression in frontal cortex of four genetically modified mouse models of depression

    European Neuropsychopharmacology, Vol. 21, Núm. 1, pp. 3-10

2010

  1. Regulation of markers of synaptic function in mouse models of depression: Chronic mild stress and decreased expression of VGLUT1

    Journal of Neurochemistry, Vol. 114, Núm. 5, pp. 1302-1314

  2. Sustained stress-induced changes in mice as a model for chronic depression

    Psychopharmacology, Vol. 210, Núm. 3, pp. 393-406

2007

  1. Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1)

    European Journal of Neuroscience, Vol. 25, Núm. 1, pp. 281-290

2005

  1. Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment

    Journal of Neurochemistry, Vol. 94, Núm. 4, pp. 875-883

2004

  1. Glutamate receptor activation is involved in 5-HT2 agonist-induced Arc gene expression in the rat cortex

    Neuropharmacology, Vol. 46, Núm. 3, pp. 331-339

2003

  1. Antidepressant drug treatment induces Arc gene expression in the rat brain

    Neuroscience, Vol. 121, Núm. 4, pp. 975-982

  2. Effect of different 5-HT1A receptor antagonists in combination with paroxetine on expression of the immediate-early gene Arc in rat brain

    Neuropharmacology, Vol. 44, Núm. 7, pp. 893-902

  3. Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration

    Journal of Neurochemistry, Vol. 85, Núm. 6, pp. 1480-1487